Connect with a Genome Editing Therapeutics Community Developed over 7 Years
The genome editing therapeutics space has matured significantly. Clinical programs are advancing, regulatory frameworks are evolving and patient need has never been greater.
Yet consistent safety profiles, extrahepatic delivery, off-targeting toxicity and manufacturing scalability remain as barriers separating promising therapies from patients in need.
That's exactly what the 7th Genome Editing Therapeutics Summit is here to address. Regulators and biopharma have shown their willingness to push forward.
Now it's your turn.
Hear What Our Sponsors Have to Say
The intimate group of scientists working in genome editing and the cell and gene therapy space along with the curated topics are seminal to drive the field forward.
2026 Sponsor, Aldevron
The small scale made the networking very effective as it was easy to talk to many experts in the field. The attendees were well-chosen making it worthwhile.
2026 Sponsor, Broken String Biosciences
This meeting unites a focused community of R&D, translational, preclinical, analytical and manufacturing genome editing decision-makers with the solution providers they need to answer one question: how do we progress genome editing therapies to patients fast but safely?
Biopharma is actively seeking CDMOs, construct providers, genome sequencing and analysis vendors, CROs, and preclinical model providers. Join Intellia Therapeutics, Beam Therapeutics, Sanofi, Prime Medicine and others in the collective effort to move more genome editing therapies through the clinic and into the hands of patients waiting for them.
What to Expect?
Own Your Position in a Genome Editing Community 7 Years in the Making
Connect with a curated audience of genome editing decision-makers who are actively progressing therapies toward patients to open new commercial conversations and deepen the partnerships that will define your growth in this space.
Stay Ahead of What Genome Editing Biopharma Needs Next
Sit in on unfiltered discussions from preclinical, clinical and commercial stage biopharma on the exact challenges limiting their programs today to ensure your solutions are positioned where they add the most value when it matters most.
Become the Partner Genome Editing Leaders Turn to First
Align your brand with the companies driving safety and clinical progress in genome editing therapeutics to build the credibility and trust that keeps your company front of mind when key decisions are being made.
Key Interest Areas
Our genome editing attendees are looking for service and solution providers with capabilities in the below areas but not limited to:
Contract Development & Manufacturing Organizations (CDMO)
Genome Sequencing & Analysis
Construct Providers
Contract Research Organizations (CROs)
Preclinical Modeling Providers
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Available Inventory
We have a range of partnership opportunities from presenting slots and exhibition spaces to bespoke hosted experiences, designed to put your solutions in front of the genome editing decision-makers who need them most:
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Jack Waring
Partnerships Director
Maintain Your Competitive Edge
Position your solutions at the heart of the genome editing therapeutics conversations shaping the next wave of clinical development.
Network With Decision-Makers
Connect directly with R&D, preclinical, regulatory and c-suite genome editing leaders during dedicated networking sessions and meeting breaks.
Showcase Your Capabilities
Explore bespoke partnership options across presenting, exhibiting and hosted experiences to build a package that puts your brand where it matters most.